Aegisy可回收式腔靜脈濾器置入術(shù)治療上腔靜脈系統(tǒng)血栓患者的效果

打開文本圖片集

Effect of Aegisy Retrievable Vena Cava Filter Implantation in the Treatment of Patients with Superior /ena Cava System Thrombosis/.//Medical Innovation of China， 2025， 22（10）： 062-065

[Abstract]Objective： To investigate the influence of Aegisy retrievable vena cava filter on blood routine indexes and the incidence of pulmonary embolism （PE）in patients with superior vena cava system thrombosis. Method： A total of 90 patients with superior vena cava system thrombosis treated in Zibo Expo High-tech Hospital fromJanuary2021toDecember2023were selectedanddividedinto venacava filter group（n=47）andconventional group （ n =43） according to different treatment methods.The vena cava filter group was treated by Aegisy recyclable vena cava filter implantation.The conventional group only received conventionalanticoagulation and thrombolytic therapy.The platelet count （PLT），hemoglobin （Hb），hematocrit （HCT），thecure rate of thrombosis and the incidence of PE were observed before and after treatment.The success rate， recovery rate and incidence of adverse reactions of filter implantation in thevena cava filter group werecalculated. Result：All47 patients who underwent Aegisy retrievablevena cava filter implantationsuccessullyhadfilterimplantation， with an implantation successrateof 100% ， and only l patient had slight filter displacement after surgery.Before and after treatment， there were no significant differences in PLT， Hb and HCT between the two groups （ Pγ >0.05）. There was no significant difference in the cure rate of thrombosis between the two groups （ P >0.05）. The incidence of PE in vena cava filter group was lower than that in conventional group， the difference was statistically significant （ P <0.05）. Of the 47 patients， 31 underwent filter extraction 2 weeks after surgery，of which28 patients were successfully removed， and thefilter recovery rate was 90.32% （28/31）. Conclusion： Compared with conventional treatment， Aegisy retrievable vena cava filter implantation hasabetter effect on the preventionof PE in patients with superior venacavasystem thrombosis， and has less impact on platelet aggregation and bleeding， posing no threat to patients'liver， kidney and other organs.

肺栓塞（PE）是靜脈血栓（DVT）常見的并發(fā)癥，被譽(yù)為高致死性危急重癥，對罹患DVT的患者來說具有較大的生命威脅，故而預(yù)防PE成為治療DVT 的關(guān)鍵，臨床以下腔DVT多見-2]。（剩余5744字）